Sexual Problems in Men
Methodology & AI Transparency ⓘ
Sexual Problems in Men Key Takeaways
Translated by Sarah Jenkins (AI RN Plain-English Translator) at a 7th-grade reading level
- 1 What it does: Many men have sexual problems.
- 2 Real-world patient consensus: Mapped to Men's Health, Testosterone & Sexual Function under ICD-10-CM N52.5 for Sexual Problems in Men clinical workups.
- 3 Typical cash cost range: Workup highlights for Sexual Problems in Men (N52.5): blood pressure) [Sexual Problems in Men N52.5].
- 4 Top reported side effects / signs: Follow-up benchmark in Sexual Problems in Men: maintaining Hematocrit & Total in Sexual Problems in Men (N52.5: PSA) within Hct < 50%; age-appropriate PSA (N52.5).
Ask our AI Specialists anything about Sexual Problems in Men
What Is Sexual Problems in Men?
Many men have sexual problems. They become more common as men age. Problems can include: Erectile dysfunction Reduced or lost interest in sex Problems with ejaculation Low testosterone Stress, illness, medicines, or emotional problems may also be factors. Occasional problems with sexual function are common. If problems last more than a few months or cause distress for you or your partner, you should see your health care provider.
Pathophysiology, Underlying Causes & Clinical Presentation
Underlying Sexual Problems in Men (code N52.5) is primary testicular Leydig in Sexual Problems in Men (N52.5: cell insufficiency or), Cross-referenced with NIH MeSH (Sexual Dysfunction, Physiological), which Men's Health, Testosterone & Sexual Function clinicians address while surveilling Hematocrit & Total in Sexual Problems in Men (N52.5: PSA) (Hct < 50%; age-appropriate PSA (N52.5)).
Common Symptoms & Clinical Signs
- • Erectile dysfunction
- • Reduced or lost interest in sex
- • Presentation of Sexual Problems in Men (N52.5): loss of lean in Sexual Problems in Men (N52.5: muscle recovery, rising)
- • Secondary Sexual Problems in Men clinical sign: blunted motivation, depressed in Sexual Problems in Men (N52.5: mood, or declining)
Primary Federal Reference: NIH / National Library of Medicine MedlinePlus Entry ↗
Sexual Problems in Men Diagnostic Classification & Lab Markers
| Metric | Verified Benchmark | Source |
|---|---|---|
| ICD-10-CM Diagnostic Code | N52.5 | WHO / CMS ICD-10-CM Clinical Classification |
| Clinical Specialty Hub | Men's Health, Testosterone & Sexual Function | NIH MedlinePlus Health Topics |
| Diagnostic / Lab Marker: Hematocrit & Total in Sexual Problems in Men (N52.5: PSA) | Hct < 50%; age-appropriate PSA (N52.5) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Ultrasensitive Estradiol & in Sexual Problems in Men (N52.5: ApoB) | E2 20–38 pg/mL; ApoB < 80 mg/dL (N52.5) | Clinical Reference Target Range |
| Diagnostic / Lab Marker: Morning Total & in Sexual Problems in Men (N52.5: Free Testosterone (2x) | Total 500–900 ng/dL; Free 110–210 pg/mL (N52.5) | Clinical Reference Target Range |
FDA-Monographed Medications & Public Cash Price Reference for Sexual Problems in Men
Treatment selection for Sexual Problems in Men depends on clinical severity, diagnostic lab results, and medical history. Search any prescribed medication in the DotMD A–Z Medication Index to view FDA DailyMed dosing and CMS NADAC wholesale acquisition pricing.
Peer-Reviewed Human Clinical Trials & Meta-Analyses (Sexual Problems in Men)
| Study & Plain-English Finding | Sample (N) | Rigor | Primary Source |
|---|---|---|---|
| New Insights on Baseline Total Testosterone Level on Successful Treatment of Sexual Dysfunction: What a 1,075-Participant Study Found Low TT levels at baseline did not negatively influence response to tadalafil in men of advancing age with concomitant lower urinary tract symptoms and benign prostatic hyperplasia and erectile dysfunction. The journal of sexual medicine • 2016-05-15 • Randomized Controlled Trial | N = 1,075 | 96/100 | PMID 27017071 ↗ |
| New Insights on Modeling and simulation of sexual activity daily diary data of patients with: What a 614-Participant Study Found A modeling and simulation framework to support drug development in FSAD was developed. Pharmaceutical research • 2006-08-15 • Randomized Controlled Trial | N = 614 | 93/100 | PMID 16841199 ↗ |
| New Insights on Tadalafil on lower urinary tract symptoms secondary to benign prostatic: What a 505-Participant Study Found Tadalafil was efficacious and well tolerated in treating ED and LUTS/BPH in sexually active men with both conditions. The journal of sexual medicine • 2013-08-15 • Randomized Controlled Trial | N = 505 | 93/100 | PMID 23782459 ↗ |
| New Insights on Benefits and safety of tadalafil 5 mg once-daily in Asian men with both lower: What a 361-Participant Study Found Tadalafil is efficacious and well tolerated in the treatment of Asian men with both lower urinary tract symptoms associated with benign prostatic hyperplasia and erectile dysfunction. International journal of urology : official journal of the Japanese Urological Association • 2019-02-15 • Phase III Randomized Trial | N = 361 | 93/100 | PMID 30362173 ↗ |
| What the Latest Evidence Really Says About Meta-analysis of phosphodiesterase type 5 inhibitors for the treatment of female PDE5is could be an effective treatment modality for female sexual dysfunction. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics • 2016-05-15 • Meta-Analysis | Multi-cohort | 92/100 | PMID 26797204 ↗ |
Sexual Problems in Men Patient Community & “People Like Me” Threads
Filter Sexual Problems in Men community threads and patient logs by age, biological sex, dosage, and treatment duration.